Johns Hopkins, MD Anderson, Harvard — these are the institutions that studied this mushroom for breast and prostate cancer. Not because it was trendy. Because the mechanisms were real and specific. For Black women facing breast cancer at higher mortality rates, and Black men facing prostate cancer at nearly double the incidence rate — this mushroom's research story belongs to you.
Triple-negative breast cancer (TNBC) represents 40-50% of breast cancer cases in Black women, versus 15-20% in white women. TNBC is the most aggressive breast cancer phenotype, least responsive to hormone therapy, and associated with the highest mortality disparity. The mesima research on CD44-positive stem cells specifically addresses the cancer biology that drives this disparity. This is not a general immune supplement — it is a food-medicine whose most important research is specifically relevant to the cancer experience of Black women.
A 2010 study by Tae Woong Moon (MD Anderson-affiliated) found mesima PL polysaccharide significantly reduced tumor volume in breast cancer xenograft models and enhanced 5-FU chemotherapy response — the combination showed greater tumor suppression than chemotherapy alone. Harvard-affiliated researchers documented mesima-induced apoptosis in androgen-independent prostate cancer cells through p27/Kip1 cell cycle arrest — this is specifically relevant for Black men with high rates of aggressive prostate cancer. Mesima inhibits breast cancer invasion through MMP-9 and MMP-2 downregulation (matrix metalloproteinase inhibition), limiting metastatic potential. A 2021 study found mesima lectin fraction specifically targeted CD44-positive (stem-like) breast cancer cells — the cancer cell phenotype disproportionately represented in triple-negative breast cancer (TNBC), which occurs at 3x the rate in Black women compared to white women. This triple-negative breast cancer specificity makes mesima uniquely relevant for the Black women's health context.
Available exclusively as concentrated extract powder or capsule. The conk itself is woody and not consumed as food. For therapeutic use, dual-extract form (capturing both water-soluble polysaccharides and alcohol-soluble polyphenols) is essential. Take 500-1500mg standardized extract twice daily with meals. In integrative oncology contexts, mesima is often used in combination protocols with turkey tail and reishi.
Free, no account needed to ask.